Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TCRR | ZTS | TAK | CTLT | GRFS |
| Company | Tcr2 Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Catalent Inc | Grifols S.A. ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NASDAQ |
| Open | 1.5800 | 198.23 | 14.82 | 60.35 | 8.93 |
| High | 1.6300 | 200.33 | 14.94 | 60.35 | 9.16 |
| Low | 1.4800 | 191.31 | 14.82 | 59.99 | 8.82 |
| Last | 1.4800 | 193.24 | 14.93 | 60.11 | 9.08 |
| Change | -0.0900 | -3.24 | +0.11 | -0.21 | +0.34 |
| % Change | -5.73% | -1.65% | +0.74% | -0.35% | +3.89% |
| Volume | 3,913,300 | 2,463,000 | 1,119,000 | 1,979,200 | 2,763,900 |
| 20-Day Average Volume | 474,175 | 1,745,470 | 1,599,820 | 1,640,630 | 1,552,860 |
| Previous Close | 1.5700 | 196.48 | 14.82 | 60.32 | 8.74 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8315 | 187.87 | 14.88 | 60.03 | 8.94 |
| 20-Day Raw Stochastic | 0.00% | 64.81% | 64.29% | 46.04% | 67.76% |
| 20-Day Relative Strength | 35.83% | 61.30% | 61.34% | 57.52% | 58.32% |
| Weighted Alpha | -29.20 | +12.87 | +0.43 | +34.09 | +32.62 |
| Today's Opinion | 8% Buy | 88% Buy | 88% Buy | 96% Buy | 88% Buy |
| Previous Opinion | 24% Buy | 88% Buy | 72% Buy | 96% Buy | 72% Buy |
| Last Month's Opinion | 56% Buy | 72% Buy | 56% Buy | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.45% since 05/23/23 | +1.33% since 09/12/24 | +0.74% since 09/12/24 | +0.70% since 09/12/24 | -0.33% since 09/12/24 |
| Low | 1.4800 on 05/31/23 | 190.13 on 09/13/24 | 14.66 on 09/13/24 | 59.51 on 09/13/24 | 8.69 on 09/18/24 |
| High | 1.7800 on 05/24/23 | 200.33 on 09/19/24 | 14.94 on 09/17/24 | 60.50 on 09/17/24 | 9.35 on 09/13/24 |
| 1-Month | |||||
| %Chg | -16.15% since 04/28/23 | +4.75% since 08/19/24 | +1.43% since 08/19/24 | +1.18% since 08/19/24 | +26.46% since 08/19/24 |
| Low | 1.4800 on 05/31/23 | 180.18 on 08/23/24 | 14.66 on 09/13/24 | 59.04 on 08/21/24 | 7.09 on 08/20/24 |
| High | 2.0400 on 05/08/23 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 61.20 on 08/30/24 | 9.57 on 08/29/24 |
| 3-Month | |||||
| %Chg | +18.40% since 02/28/23 | +13.90% since 06/18/24 | +17.84% since 06/18/24 | +9.15% since 06/18/24 | +29.34% since 06/18/24 |
| Low | 1.1521 on 03/03/23 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 54.55 on 06/20/24 | 5.79 on 06/27/24 |
| High | 2.0400 on 05/08/23 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 61.20 on 08/30/24 | 9.57 on 08/29/24 |
| 6-Month | |||||
| %Chg | +13.85% since 11/28/22 | +11.73% since 03/19/24 | +3.61% since 03/19/24 | +7.44% since 03/19/24 | +49.83% since 03/19/24 |
| Low | 0.8210 on 12/23/22 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 53.51 on 05/29/24 | 5.79 on 06/27/24 |
| High | 2.0400 on 05/08/23 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 61.20 on 08/30/24 | 9.57 on 08/29/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 58,108 | 88,174,448 | 47,251,016 | 10,878,708 | 6,243,045 |
| Shares Outstanding, K | 39,262 | 456,295 | 3,164,837 | 180,980 | 687,560 |
| Annual Sales | 0 | 8,544,000,000 | 29,419,960,000 | 4,381,000,000 | 7,134,500,000 |
| Annual Net Income | -151,820,000 | 2,344,000,000 | 994,060,000 | -1,043,000,000 | 64,200,000 |
| Last Quarter Sales | 0 | 2,361,000,000 | 7,731,140,000 | 1,301,000,000 | 1,957,700,000 |
| Last Quarter Net Income | -40,400,000 | 624,000,000 | 609,590,000 | 23,000,000 | 15,980,000 |
| 60-Month Beta | 1.94 | 0.88 | 0.54 | 1.15 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 05/11/23 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 0.65 on 08/29/24 | 0.02 on 07/30/24 |
| Latest Earnings Date | 05/11/23 | 11/07/24 | 10/24/24 | 09/03/24 | 08/01/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | 0.370 on 06/03/21 |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | 06/03/21 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 35.47 | 9.44 | 0.00 | 0.00 |